SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 74 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $6,022,000 | +48.6% | 335,539 | -2.3% | 0.00% | +100.0% |
| Q3 2017 | $4,053,000 | +12.5% | 343,445 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $3,603,000 | +7.3% | 343,167 | +12.4% | 0.00% | 0.0% |
| Q1 2017 | $3,359,000 | -17.8% | 305,418 | +1.3% | 0.00% | 0.0% |
| Q4 2016 | $4,086,000 | +7.9% | 301,584 | -2.0% | 0.00% | 0.0% |
| Q3 2016 | $3,788,000 | +18.1% | 307,766 | +5.3% | 0.00% | 0.0% |
| Q2 2016 | $3,207,000 | -10.1% | 292,392 | -10.5% | 0.00% | 0.0% |
| Q1 2016 | $3,569,000 | -32.3% | 326,547 | +7.1% | 0.00% | -50.0% |
| Q4 2015 | $5,273,000 | -10.0% | 304,947 | +3.4% | 0.00% | 0.0% |
| Q3 2015 | $5,858,000 | +55.4% | 294,799 | +28.5% | 0.00% | +100.0% |
| Q2 2015 | $3,769,000 | +12.6% | 229,422 | +6.7% | 0.00% | 0.0% |
| Q1 2015 | $3,347,000 | +7.4% | 215,090 | -1.4% | 0.00% | 0.0% |
| Q4 2014 | $3,116,000 | +115.0% | 218,188 | -2.1% | 0.00% | – |
| Q3 2014 | $1,449,000 | +9.8% | 222,945 | +16.5% | 0.00% | – |
| Q2 2014 | $1,320,000 | -9.2% | 191,347 | -5.9% | 0.00% | – |
| Q1 2014 | $1,454,000 | -30.2% | 203,379 | -8.2% | 0.00% | -100.0% |
| Q4 2013 | $2,083,000 | +45.9% | 221,585 | -3.2% | 0.00% | 0.0% |
| Q3 2013 | $1,428,000 | -6.5% | 228,937 | -1.3% | 0.00% | 0.0% |
| Q2 2013 | $1,527,000 | – | 231,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 311 | $6,000 | 0.00% |
| NOMURA HOLDINGS INC | 33,500 | $599,000 | 0.00% |
| IFP Advisors, Inc | 384 | $7,000 | 0.00% |
| GLENMEDE TRUST CO NA | 461 | $8,000 | 0.00% |